In this review:

  • Contemporary guideline-directed medical therapy for heart failure
  • Association of coagulation factor XI levels with cardiac function
  • Outcomes with GLP-1 receptor agonists in patients with heart failure
  • Heart rate reduction alone produces reverse remodelling in heart failure patients
  • Interactive effects of statins, obesity, and cardiorespiratory fitness in
  • T2DM
  • SGLT2 inhibitors versus sulfonylureas as add-on therapy to metformin in
  • T2DM
  • Synchronous care in cardiovascular disease
  • Genotype-phenotype mismatch of hereditary transthyretin cardiac amyloidosis
  • A shocking encounter with AL cardiac amyloidosis
  • Systemic sclerosis masquerading as heart failure

Download the AHA 2023 Conference Review here